INDIVUMED GmbH
Indivumed is a biotech company focused on precision oncology. We discover therapeutically novel targets for the development of precision cancer therapeutics and strive for a future in which every cancer patient can benefit from precise therapeutic treatments.
To achieve this goal, we dedicate our skills and knowledge in cancer research to the identification, validation, and preclinical development of first-in-class therapeutics. With more than twenty years of experience and a truly unique resource, based on a standardized collection process that secures a cold ischemia time of under 10 minutes, we are committed to transforming oncology and bringing the best possible therapies to patients.
-
Mitarbeiterzahl
90 -
Kategorien
- Bioanalytik
- Therapie-Entwickler
-
Gegründet
2002 -
Aktualisiert am
08.04.2025